Nature’s Sunshine Products Inc reported steady second-quarter performance ending June 2026, maintaining its broad direct selling nutritional supplement and personal care portfolio through a global independent consultant network. The company continues to navigate complex regulatory environments, particularly trade compliance and direct selling laws in key Asian markets. With operations focused on quality control and consultant engagement, geographic diversification remains a key strategic pillar, although regulatory risks and consultant retention pose ongoing challenges. Financially, the firm shows a strong liquidity position supporting strategic flexibility.